Baxter Healthcare Corporation recalls Cefazolin in Dextrose
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Presence of Particulate Matter
- Products
-
- Cefazolin in Dextrose
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- 19,032 bags
- About this recall
- Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.